The demise of HRT? The long-term safety of hormone replacement therapy

Bibliography

• GRODSTEIN F, STAMPFER M: The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc. Dis. (1995) 38:199–210.
   PubMed Web of Science ®Google Scholar
• GRODSTEIN F, STAMPFER MJ: Estrogen for women at varying risk of coronary artery disease. Maturitas (1998) 30:19–26.
   PubMed Web of Science ®Google Scholar
• TORGERSON DJ, BELL-SEYER SE: Hormone replacement therapy and prevention of non-vertebral fractures: a meta-analysis of randomised trials. JAMA (2001) 285:2891–2897.
   PubMed Web of Science ®Google Scholar
• GRADY D, RUEBEN SB, PETTITI DB et al.: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. (1992) 117:1016–1037.
   PubMed Web of Science ®Google Scholar
• GERHARDSSON DE VERDIER M, LONDON S: Reproductive factors, exogenous female hormones and colorectal cancer by subsite. Cancer Causes Control (1992) 3:355–360.
   PubMed Web of Science ®Google Scholar
• BIRGE S: Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?" Am. Geriatr. Soc. (1996) 44:865–870.
   PubMed Web of Science ®Google Scholar
• WORZALA K, HILLER R, SPERDUTO RD et al.: Postmenopausal estrogen use, type of menopause and lens opacities: the Framingham studies. Arch. Intern. Med (2001) 161:1448–1454.
   PubMed Web of Science ®Google Scholar
• PAGANINI-HILL k The benefits of estrogen replacement therapy on oral health. The Leisure World cohort. Arch. Intern. Med. (1995) 155:2325–2329.
   PubMed Web of Science ®Google Scholar
• GRODSTEIN F, COLDITZ GA, STAMPFER MJ: Post-menopausal hormone use and tooth loss: a prospective study. J. Am. Dent. Assoc. (1996) 127:370–377.
   PubMed Web of Science ®Google Scholar
• CARDOZO L, BACHMANN G, MCCLISH D, FONDA D, BIRGERSON L: Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet. Gynecol (1998) 92:722–727.
   PubMed Web of Science ®Google Scholar
• THE WRITING GROUP FOR THE PEPI TRIAL: Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. JAMA (1995) 273:199–208.
   PubMed Web of Science ®Google Scholar
• •Randomised controlled trial examining the effect of conjugated equine oestrogens and progestins on surrogate cardiovascular end points.
   Google Scholar
• SAMAAN SA, CRAWFORD MH: Estrogen and cardiovascular function after menopause./ Am. Coll. Cardiol (1995) 26:1403–1410.
   PubMed Web of Science ®Google Scholar
• HULLEY S, GRADY D, BUSH T et al: Randomised trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA (1998) 280:605–613.
   PubMed Web of Science ®Google Scholar
• ••Overview of HERS data.
   Google Scholar
• WENGER NK, KNATTERUD GL, CANNER PL: Early risks of hormone replacement therapy in patients with coronary heart disease. JAMA (2000) 284:41-43. Letter.
   Google Scholar
• ROSSOUW JE: Early risk of cardiovascular events after commencing hormone replacement therapy. Curr. Opin. Lipidol. (2001) 12:371–375.
   PubMed Web of Science ®Google Scholar
• •A review of the possible role of oestrogen in increasing cardiovascular event rate.
   Google Scholar
• HODIS HN, MACK WJ, LOBO RA et al.: Estrogen in the prevention of atherosclerosis. Ann. Intern. Med. (2001) 135:939–953.
   PubMed Web of Science ®Google Scholar
• HERRINGTON DM, ESPELAND MA, CROUSE JR III et al: Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler. Thromb. Vasc. Biol. (2001) 21:1955–1961.
   PubMed Web of Science ®Google Scholar
• WATERS DD, ALDERMAN EL, HSIA J et al: Effects of hormone replacement therapy and anti-oxidant vitamin supplements on coronary atherosclerosis in postmenopausal women. JAMA (2002) 288:2432–2440.
   PubMed Web of Science ®Google Scholar
• HERRINGTON DM, REBOUSSIN DM, BROSNIHAN KB et al: Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N Engl. J. Med. (2000) 343:522–529.
   PubMed Web of Science ®Google Scholar
• ANGERER P, STORKS, KOTHNY W et al: Effect of post-menopausal estrogen replacement on atherosclerosis in femoral arteries. Maturitas (2002) 41:51–60.
   PubMed Web of Science ®Google Scholar
• ANGERER P, STORKS, KOTHNY W et al: Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomised controlled trial. Arterioscler. Thromb. Vasc. Biol. (2001) 21:262–268.
   PubMed Web of Science ®Google Scholar
• VISCOLI CM, BRASS LM, KERNAN WN, SARREL PM, SUISSA S, HORWITZ RI: A clinical trial of estrogen-replacement therapy after ischaemic stroke. N Engl. J. Med. (2001) 345:1243–1249.
   PubMed Web of Science ®Google Scholar
• MUSGRAVE DS, VOGT MT, NEVITT MC et al: Back problems among postmenopausal women taking estrogen replacement therapy. The Study of Osteoporotic Fractures. Spine (2001) 26:1606–1612.
   PubMed Web of Science ®Google Scholar
• GRADY D, BROWN JS, VITTINGHOFF E et al.: Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gyneco/. (2001) 97:116–120.
   PubMed Web of Science ®Google Scholar
• MULNARD RI, COTMAN CW, KAWAS C et al: Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease. A randomised controlled trial. /AMA (2000) 283:1007–1015.
   Google Scholar
• WRITING GROUP FOR THE WOMEN'S HEALTH INITIATIVE INVESTIGATORS: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. /AMA (2002) 288:321–333.
   Google Scholar
• ••Overall results from the WHI.
   Google Scholar
• THE ESPRIT TEAM: Oestrogen therapyfor prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet (2002) 360:2001–2008.
   PubMed Web of Science ®Google Scholar
• CLARKE SC, KELLEHER J, LLOYD-JONES H, SLACK M, SCHOFIELD PM: Transdermal estrogen-progestin therapy increases rates of CHD events in women with heart disease. Br. J. Obstet. Gynaecol (2002) 109:1056–1062.
   Google Scholar
• MILLER VT, MUESING RA, LAROSA JC, STOY DB, PHILLIPS EA, STILLMAN RJ: Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions and apolipoprotein A-1. Obstet. Gynecol (1991) 77:235–240.
   PubMed Web of Science ®Google Scholar
• MENDELSOHN ME, KARAS RH: The protective effects of estrogen on the cardiovascular system. N Engl. J. Med. (1999) 340:1801–1811.
   PubMed Web of Science ®Google Scholar
• COLLABORATIVE GROUP ON HORMONAL FACTORS IN BREAST CANCER: Breast cancer and hormone 344 Expert Op/n. Drug Saf. (2003) 2(4) replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet (1997) 350:1047–1059.
   Google Scholar
• •Meta-analysis of the effects of oestrogen on breast cancer risk.
   Google Scholar
• SCHAIRER C, LUBIN J, TROISI R, STURGEON S, BRINTON L, HOOVER R Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA (2000) 283:485–491.
   PubMed Web of Science ®Google Scholar